Increased Levels of Circulating IGFBP4 and ANGPTL8 with a Prospective Role in Diabetic Nephropathy

• Published in: International journal of molecular sciences Vol. 24; no. 18; p. 14244
• Main Authors: AlMajed, Hana Th, Abu-Farha, Mohamed, Alshawaf, Eman, Devarajan, Sriraman, Alsairafi, Zahra, Elhelaly, Ashraf, Cherian, Preethi, Al-Khairi, Irina, Ali, Hamad, Jose, Rose Mol, Thanaraj, Thangavel Alphonse, Al-Ozairi, Ebaa, Al-Mulla, Fahd, Al Attar, Abdulnabi, Abubaker, Jehad
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-09-2023; MDPI
• Subjects: ANGPTL8; Biomarkers; Cardiovascular disease; Correlation analysis; Creatinine; Development and progression; Diabetes; Diabetic nephropathies; Diabetic nephropathy; Ethylenediaminetetraacetic acid; Glucose; Growth hormones; IGF-binding proteins; IGFBP4; Insulin resistance; Insulin-like growth factors; Pathogenesis; Population; Protein binding; Proteins; Risk factors; Type 2 diabetes; Kuwait
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241814244

Diabetic nephropathy (DN) is a complicated condition related to type 2 diabetes mellitus (T2D). ANGPTL8 is a hepatic protein highlighted as a risk factor for DN in patients with T2D; additionally, recent evidence from DN studies supports the involvement of growth hormone/IGF/IGF-binding protein axis constituents. The potential link between ANGPTL8 and IGFBPs in DN has not been explored before. Here, we assessed changes in the circulating ANGPTL8 levels in patients with DN and its association with IGFBP-1, -3, and -4. Our data revealed a significant rise in circulating ANGPTL8 in people with DN, 4443.35 ± 396 ng/mL compared to 2059.73 ± 216 ng/mL in people with T2D (p < 0.001). Similarly, levels of IGFBP-3 and -4 were significantly higher in people with DN compared to the T2D group. Interestingly, the rise in ANGPTL8 levels correlated positively with IGFBP-4 levels in T2DM patients with DN (p < 0.001) and this significant correlation disappeared in T2DM patients without DN. It also correlated positively with serum creatinine and negatively with the estimated glomerular filtration rate (eGFR, All < 0.05). The area under the curve (AUC) on receiver operating characteristic (ROC) analysis of the combination of ANGPTL8 and IGFBP4 was 0.76 (0.69–0.84), p < 0.001, and the specificity was 85.9%. In conclusion, our results showed a significant increase in ANGPTL8 in patients with DN that correlated exclusively with IGFBP-4, implicating a potential role of both proteins in the pathophysiology of DN. Our findings highlight the significance of these biomarkers, suggesting them as promising diagnostic molecules for the detection of diabetic nephropathy.